lobbying_activities: 3336850

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3336850	8dc55539-8bd3-4ba8-a3df-313b57a895b5	Q1	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2025	first_quarter	MED	* ADLM conducted a briefing for congressional staff on the impact of the Food and Drug Administration laboratory developed test rule on children's health. * ADLM endorsed the Freedom for Lab Innovation and Testing Act, which would prevent the FDA from using federal funds to implement the LDT rule; the association also initiated a grassroots campaign in support of the bill. * ADLM joined a coalition letter to House and Senate leaders seeking congressional support for getting public health data restored to agency websites. * ADLM released a position statement raising concerns about barriers to children getting laboratory testing.	HOUSE OF REPRESENTATIVES,SENATE		130000	0	0	2025-04-16T12:24:20-04:00